Research Highlights:

  • Genetics enhances the role sex plays to increase the risk of stroke and heart attack in healthy middle-aged adults.
  • In the future, genetic risk scores may be used to assess stroke and heart attack risk and develop preventive efforts specific to people in middle-age without obvious risks.

Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, Feb. 12, 2020

DALLAS, Feb. 12, 2020 — Genetics enhances the role sex plays in determining risk for stroke and heart attack in healthy middle-aged adults (ages 40 to 60), according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2020 – Feb. 19-21 in Los Angeles, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.

Currently, the genetic risk score employed in this study is widely used in research, however, it is not yet used in the clinical care of patients. The findings support the possibility that genetic scores could be used to better assess the likelihood of stroke and heart attack and develop and implement preventive efforts for middle-aged people without obvious risks.

“The risk of heart attack or stroke increases rapidly during middle age,” said Guido J. Falcone, M.D., Sc.D., M.P.H., lead author of the study and assistant professor of neurology at the Yale School of Medicine in New Haven, Connecticut. “Identifying healthy middle-aged adults at higher risk to have a stroke or heart attack is important because it opens the possibility of intervening early and avoiding many years of disability.”

The researchers analyzed data from more than 300,000 people (59% women) enrolled in the UK Biobank, an open-access, UK-based resource that recruited half a million people in the United Kingdom (aged 40-69) between 2006 and 2010. All UK Biobank volunteers agreed to undergo medical testing, provide detailed health information and have their health followed in the future. None of the participants in this analysis had high blood pressure, diabetes or high cholesterol at the time they enrolled. No participants had a prior heart attack or stroke, and all were screened for the presence of 68 gene variants that are known to be associated with the risk of heart attack or stroke. This data generated a single score that allowed the categorization of each study participant as having low, intermediate or high genetic risk.

By age 60, there were 1,954 strokes and 3,792 heart attacks. Analyzing the influence of sex and genetics, researchers found:

  • The proportion of people who had a heart attack or stroke was approximately 1 in 800 by age 40, 1 in 220 by age 50, and 1 in 76 by age 60;

  • Compared to people at low genetic risk, strokes and heart attacks increased 22% in those at intermediate risk and increased 52% among those at high genetic risk;

  • Men were three times as likely as women to have a stroke or heart attack; and

  • Compared to women at low genetic risk, men at high genetic risk were four times as likely to have a stroke or heart attack.

“We were very surprised by the results, especially the synergy between genetic burden and sex,” Falcone said. “I am cautiously optimistic. We already know that treatment for high blood pressure, high cholesterol and diabetes can help prevent heart attacks and strokes. People without these conditions who are at high genetic risk could also benefit from some type of early intervention, and the findings from our study may help us develop preventive measures for this population.”

Results from this study, which included an almost entirely white, British population enrolled in the UK Biobank, may not be generalizable to other racial and ethnic groups. “These results would apply to a specific group of Americans, and we would need to test all these things in other ethnic or racial groups, including Native Americans, African Americans, Hispanics and Asians,” Falcone said.

Co-authors are Julian Acosta, M.D.; Audrey C. Leasure, B.S.; Kevin N. Vanent, B.S.; Rommell B. Noche, B.S.; Elayna Kirsch, B.S.; Nils H. Petersen, M.D.; Joseph Schindler, M.D.; Lauren H. Sansing, M.D., M.S.; Thomas M. Gill, M.D.; Charles C. Matouk, M.D.; Murat Gunel, M.D.; and Kevin N. Sheth, M.D. Author disclosures are available in the abstract.

The study was funded by the National Institute of Neurological Disorders and Stroke and the National Institute on Aging at the National Institutes of Health, the American Heart Association and the Neurocritical Care Society.

Additional Resources:

Statements and conclusions of study authors that are presented at American Stroke Association scientific meetings are solely those of the study authors and do not necessarily reflect Association policy or position. The Association makes no representation or warranty as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at

The American Stroke Association’s International Stroke Conference (ISC) is the world’s premier meeting dedicated to the science of stroke and brain health. ISC 2020 will be held February 19-21 at the Los Angeles Convention Center in California. The 2 ½-day conference features more than 1,600 compelling scientific presentations in 21 categories that emphasize basic, clinical and translational science for health care professionals and researchers. These science and other clinical presentations will provide attendees with a better understanding of stroke and brain health to help improve prevention, treatment and outcomes for the more than 800,000 Americans who have a stroke each year. Stroke is the fifth leading cause of death and a leading cause of serious, long-term disability in the U.S. Worldwide, cerebrovascular accidents (stroke) are the second leading cause of death and the third leading cause of disability, according to the World Health Organization. Engage in the International Stroke Conference on social media via #ISC20.

About the American Stroke Association

The American Stroke Association is a relentless force for a world with fewer strokes and longer, healthier lives. We team with millions of volunteers and donors to ensure equitable health and stroke care in all communities. We work to prevent, treat and beat stroke by funding innovative research, fighting for the public’s health, and providing lifesaving resources. The Dallas-based association was created in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit Follow us on Facebook and Twitter.


For Media Inquiries and ASA Expert Perspective: 214-706-1173

Karen Astle: 214-706-1392;

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

Feb. 19-21, 2020: AHA News Media Office, Los Angeles Convention Center: 213-743-6201 and